Skip to main content

Table 4 Repeated measure ANCOVAs of 12-month follow-up measured by GAF and SF-36

From: Psychosocial functioning in patients with treatment-resistant depression after group cognitive behavioral therapy

 

Pre-treatment Mean (SD)

Post-treatment Mean (SD)

12 months Mean (SD)

F value

effect size partial Eta 2

ITT (N = 32)

     

GAF

60.62(6.36)

66.41(6.74)a

71.22(9.16)b, c

21.44***

0.32

SF-36 PCS

42.23 (8.88)

48.21 (9.78)a

46.97 (9.34)b

6.71**

0.13

   Physical functioning

76.87(16.84)

84.53 (14.67)a

84.53 (14.11)b

8.28***

0.15

   Role physical

21.88(39.53)

60.16 (45.73)a

59.38 (40.54)b

11.39***

0.20

   Bodily pain

65.84(22.56)

70.73 (25.29)

74.06 (24.06)

1.87

0.04

   General health

39.78(14.92)

51.13 (20.59)a

49.91 (19.64)b

5.19**

0.10

SF-36 MCS

26.16 (9.70)

33.59 (11.20)a

38.34 (11.63)b

15.32***

0.25

   Vitality

26.41(14.66)

40.31 (19.10)a

43.75 (19.76)b

12.59***

0.22

   Social functioning

44.84(21.91)

60.55 (23.14)a

68.75 (25.79)b

10.51***

0.19

   Role emotional

13.54(31.52)

37.50 (42.12)a

54.17 (43.79)b

13.07***

0.22

   Mental health

38.13(16.51)

51.63 (18.16)a

55.83 (18.80)b

13.18***

0.22

Completers (N = 20)

     

GAF

60.24 (6.86)

66.48 (6.40)a

73.81 (7.29)b, c

25.99***

0.48

SF-36 PCS

43.80 (8.48)

50.32 (7.88)a

48.18 (7.28)

5.10**

0.15

   Physical functioning

80.25(13.13)

89.50 (9.02)a

89.00 (7.88)b

12.31***

0.31

   Role physical

21.25(40.78)

57.50 (47.37)a

56.25 (38.79)b

5.75**

0.17

   Bodily pain

66.60 (24.30)

73.28 (27.40)

76.30 (26.75)

1.34

0.05

   General health

39.55 (16.17)

55.90 (22.06)a

54.10 (21.19)b

6.94**

0.27

SF-36 MCS

25.23 (9.77)

33.78 (11.06)a

40.56 (10.71)b, c

13.91***

0.33

   Vitality

25.50 (13.66)

42.25 (16.58)a

47.25 (17.66)b

10.78***

0.28

   Social functioning

48.00 (21.86)

61.87 (26.12)

73.13 (29.32)b

8.69**

0.24

   Role emotional

13.33 (33.16)

40.00 (45.37)

63.33 (45.76)b, c

11.23***

0.29

   Mental health

34.80 (16.68)

52.00 (16.57)a

57.60 (17.38)b

15.00**

0.35

  1. *** p < .001, ** p < .01, * p < .05
  2. a: significant difference between Pre- and Post-treatment (p < .05)
  3. b: significant difference between Pre- and 12 months after treatment (p < .05)
  4. c: significant difference between Post- and 12 months after treatment (p < .05)